IndraLab

Statements


USP9X leads to the deubiquitination of Parkinson Disease on L1. 3 / 3
| 3

reach
"Taken together, these findings suggest that activated tumor signaling pathways vary in different tumor microenvironments.Interestingly, USP9X reduced the ubiquitination of PD‐L1 and stabilized its protein expression."

reach
"Ubiquitin‐specific peptidase 9, X‐linked (USP9X) inhibited the ubiquitination and degradation of PD‐L1, thereby mediating the immune escape of OSCC."

reach
"The results further validated our hypothesis that the highly expressed USP9X increased and decreased the deubiquitination and ubiquitination of PD‐L1, respectively, leading to its accumulation in OSCC cell lines.3.5 USP9X is critical in OSCC tumor growth."